Intraobserver and Interobserver Variability of Fuhrman and Modified Fuhrman Grading Systems for Conventional Renal Cell Carcinoma  by Bektas, Sibel et al.
Kaohsiung J Med Sci November 2009 • Vol 25 • No 11596
© 2009 Elsevier. All rights reserved.
Renal cell carcinoma (RCC) accounts for 90% of all
primary malignant renal tumors in adults and con-
ventional (clear cell) RCC is the most common subtype
[1–3]. Staging and nuclear grading of RCC are con-
sidered to be the strongest predictors of survival [1–5].
Several grading schemes have been developed for
RCC; the Fuhrman grading system (FGS) is currently
the most widely used nuclear grading system [4,6,7].
FGS is applicable to all RCCs of any size and with
any pattern or cell type [8]. It has been shown that this
nuclear grading has a prognostic value, particularly
for conventional and papillary RCC [7]. The Fuhrman
nuclear grading system is based on nuclear size,
shape and the prominence of nucleoli [8]. Despite the
wide-spread acceptance of the FGS, its reproducibil-
ity and interpretation variability have been ques-
tioned, mainly because of the heterogeneity of RCC
and the subjectivity of pathologists. A limited number
of studies have assessed the intraobserver and inter-
observer variability of FGS for conventional RCC [9].
FGS is a four-tiered system, although modifications
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The Fuhrman nuclear grade is the most widely used grading system for renal cell carcinoma. The
aim of this study was to evaluate the intraobserver and interobserver variability of the Fuhrman
and modified Fuhrman grading systems for conventional renal cell carcinoma. In this study, five
pathologists independently classified 110 cases of conventional renal cell carcinoma according to
the Fuhrman and modified (three- and two-tiered) Fuhrman grading systems. The intraobserver
and interobserver variability of these systems were assessed using κ statistics. The associations
between the Fuhrman and modified Fuhrman grades, pathologic stage and tumor size were
determined by correlation analysis. The intraobserver and interobserver combined mean κ val-
ues for four-tiered Fuhrman grading were 0.48 and 0.41, respectively. The highest agreement was
detected in two-tiered modification (including grades 1 + 2 and 3 + 4); the intraobserver and inter-
observer combined mean κ values were 0.67 and 0.62, respectively. Correlations between patho-
logic stage and tumor size with two-tiered modification (including grades 1 + 2 and 3 + 4) were
greater than those in three- and four-tiered Fuhrman grading. Collapsing the Fuhrman grading
into a two-tiered scheme improved the intraobserver and interobserver reproducibility.
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collapsing the system into three or two grades have
been proposed for improved reproducibility. Several
studies have showed that two-tiered grading has a
higher rate of agreement between pathologists than
original the four-tiered FGS [5,10,11]. The aim of this
study was to establish the intraobserver and interob-
server variability among five pathologists, using FGS
and three- and two-tiered modified Fuhrman grading
systems (MFGS) for conventional RCC.
MATERIALS AND METHODS
This study included 110 patients who had under-
gone radical nephrectomy for renal tumors at the
Departments of Pathology in Zonguldak Karaelmas
University School of Medicine or the Lutfi Kirdar
Kartal Training and Research Hospital between 2004
and 2007. The histologic type of all cases was the con-
ventional type. Clinical features were collected from
hospital records. All histologic sections were fixed in
formalin, embedded in paraffin, cut into 5-μm-thick
sections and stained with hematoxylin and eosin.
Slides of all cases (4–15 slides per case; median, 7) were
rescored according to FGS by five pathologists (SB,
BB, NOK, FB, and AEG) blinded to the prior scores. All
pathologists involved in this study had at least 4 years
experience of urologic malignancy and each gained
their specialization at different institutes. We did not
include cases diagnosed in 2008 to avoid “memory
bias”. Intraobserver variation was determined by each
pathologist’s observation at two different times. There
were 5-month intervals between each grading round.
Interobserver variation was determined by the second
pathologist blinded to the results of the first.
Tumors were graded as follows: grade 1 tumors
were composed of cells with small (∼10 μm), round,
uniform nuclei and inconspicuous or absent nucleoli;
grade 2 tumor cells had larger (∼15 μm) nuclei with
irregular outlines and nucleoli visible under high-
power (400×) microscopy; grade 3 tumor cells had
even larger nuclei (∼20 μm) with obviously irregular
outlines and prominent nucleoli even under low-power
(100×) microscopy; and grade 4 tumors exhibited fea-
tures similar to grade 3 tumors, but also had bizarre
and multilobed nuclei, and clumped chromatin. The
nuclear grade was assigned according to the least dif-
ferentiated tumor area [8]. An admixture of more than
one grade (i.e. 2 or 3 grades) in the same tumor was
recorded by the first pathologist (SB). In this study, the
four-tiered Fuhrman grading system was modified
into a three-tiered and then into a two-tiered scheme.
The three-tiered scheme was then subdivided into
sets 3A (grades 1, 2 and 3 + 4), 3B (grades 1, 2 + 3 and
4), and 3C (grades 1 + 2, 3 and 4). The two-tiered
scheme was also subdivided into sets 2A (grades 1
and 2 + 3 + 4), 2B (low grade: grades 1 + 2; high grade:
grades 3 + 4), and 2C (grades 1 + 2 + 3 and 4).
Data were analyzed using SPSS version 13.0 (SPSS
Inc., Chicago, IL, USA). Agreement between pairs 
of pathologists was evaluated using κ statistics for
FGS and MFGS. For positive κ values, the following
interpretations are generally accepted: marginal agree-
ment, κ<0.40; good agreement, κ=0.40–0.75; excellent
agreement, κ > 0.75 [12,13]. The χ2 test for independ-
ence was used to verify homogeneity within marginal
distributions of tumor grades. The null hypothesis 
of similarity was rejected for both grading rounds
(p < 0.001). A κ value was calculated for each pair of
pathologists and the mean κ value was also recorded
for FGS and MFGS.
All cases were staged pathologically according 
to the 2002 TNM criteria [14] by the first pathologist
(SB). Tumor size was defined and recorded as the
greatest diameter of the tumor in the pathological
specimen. The associations between FGS and MFGS
with tumor size and pathologic stage were determined
by Spearman’s correlation analysis.
RESULTS
The mean patient age (± standard deviation) was
59.25 ± 11.61 years (range, 24–81 years). Seventy-eight
(70.9%) patients were male, and 32 (29.1%) were
female. Mean maximum tumor diameter was 7.10 ±
3.3 cm (range, 1.6–15 cm). Pathologic stage was as 
follows: stage 1, 64 patients (63%); stage 2, 31 patients
(23.3%); stage 3, nine patients (4.3%); and stage 4, six
patients (4.3%).
Using FGS, the same grade was inferred by five
pathologists in 53 cases (48%). The intraobserver agree-
ment of the five pathologists ranged from 26% to 64%
for grade 1, 30% to 78% for grade 2, 35% to 87% for
grade 3, and 45% to 100% for grade 4. Intraobserver κ
values ranged from 0.39 to 0.59 (mean, 0.48). The inter-
observer agreement of the five pathologists ranged
from 17% to 72% for grade 1, 31% to 89% for grade 2,
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34% to 77% for grade 3, and 7% to 100% for grade 4.
The interobserver κ values for the first and second
rounds ranged from 0.30 to 0.51 and from 0.22 to 
0.57 (combined mean κ value = 0.41), respectively.
The coexistence of two and three different grades in
the same tumor was observed in 37 (33.64%) and 11
(10%) tumors, respectively.
Pathologic stages showed moderate correlations
with the first (r = 0.391–0.344, p = 0.01) and second
rounds (r = 0.287–0.478, p = 0.01). Tumor size was sig-
nificantly correlated, with fair to moderate strength,
with the first (r = 0.195–0.287, p = 0.01) and second
rounds (r = 0.221–0.360, p = 0.01).
The intraobserver and interobserver κ values for
the three- and two-tiered MFGS are presented in
Tables 1 and 2. The highest mean κ values between
MFGS were obtained with modification 2B. In this
scheme, the intraobserver κ values ranged from 0.57
to 0.76 (mean, 0.67); the interobserver κ values for the
first and second rounds ranged from 0.44 to 0.73 and
from 0.41 to 0.84 (combined mean κ value = 0.62), 
respectively. The highest correlation was detected
between pathologic stage and modification 2B. The
pathologic stage was strongly correlated with modi-
fication 2B in the first (r = 0.471–0.671, p = 0.01) and
second rounds (r = 0.416–0.696, p = 0.01). Furthermore,
only this scheme, of the three two-tiered schemes,
showed significant, moderate to substantial, correla-
tions with tumor size in the first (r = 0.389–0.694,
p = 0.05) and second rounds (r = 0.328–0.633, p = 0.05).
In all three-tiered MFGS, the greatest correlation
was found between pathologic stage and modifica-
tion 3C. Pathologic stage showed significant, moder-
ate to substantial, correlations with this modification 
in the first (r = 0.299–0.403, p = 0.01) and second (r =
0.385–0.543, p = 0.01) rounds. The tumor size was not
correlated with any of the three-tiered MFGS.
DISCUSSION
Several prognostic indicators including the Fuhrman
nuclear grade, TNM stage, tumor size, tumor necrosis
and histological subtype were shown to predict RCC-
specific survival [1–5,15–20]. These factors, except for
the Fuhrman nuclear grade, are objective, and the prog-
nostic role of FGS is limited by its subjective nature
and observer variability because of the poor character-
ization of nuclear and nucleolar features. The Fuhrman
nuclear grade depends on the outlines of cell nuclei,
the presence of nucleoli and the size of the nuclei.
The Fuhrman nuclear grade should be determined on
Table 1. κ values for intraobserver and interobserver variability after modifying the Fuhrman grading system into
three-tiered schemes
Intraobserver κ value Interobserver κ value
Mod Low-grade IM-grade High-grade
Min Max Mean
Min–max Min–max Combined 
(FR) (SR) mean
3A 1 2 3 + 4 0.39 0.69 0.56 0.37–0.63 0.35–0.64 0.53
3B 1 2 + 3 4 0.35 0.73 0.59 0.34–0.70 0.37–0.66 0.54
3C 1 + 2 3 4 0.42 0.75 0.61 0.33–0.71 0.32–0.65 0.57
Mod = modification; IM = intermediate; min = minimum; max = maximum; FR = first round; SR = second round.
Table 2. κ values for intraobserver and interobserver variability after modifying the Fuhrman grading system into
two-tiered schemes
Intraobserver κ value Interobserver κ value
Mod Low-grade High-grade
Min Max Mean
Min–max Min–max Combined 
(FR) (SR) mean
2A 1 2 + 3 + 4 0.31 0.72 0.53 0.45–0.66 0.40–0.66 0.55
2B 1 + 2 3 + 4 0.57 0.76 0.67 0.43–0.73 0.41–0.84 0.62
2C 1 + 2 + 3 4 0.43 0.74 0.54 0.11–0.72 0.11–0.63 0.44
Mod = modification; min = minimum; max = maximum; FR = first round; SR = second round.
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the least differentiated cell component [8]. However, the
smallest proportion of the highest-grade area, which
raises the resultant tumor grade, has not been defined.
Recently, it was proposed that the highest grade should
occupy at least one field at 400× magnification [21].
Finding the least-differentiated component is a time-
consuming procedure and requires careful investiga-
tion of all tumor slides and may contribute to grading
variability among pathologists. Inadequate tumor
sampling and suboptimal tissue fixation are also
challenging factors for the identification of the highest-
grade area. Furthermore, consistent recognition of
nucleoli and assessment of their size may be prob-
lematic, particularly in non-formalin fixed or poorly
fixed tissues. RCC is a heterogeneous tumor that is
usually composed of cells with different grades. For
example, in our series, the coexistence of two or three
grades in the same tumor was observed in 33.64% and
10% of tumors, respectively. All of these limitations of
FGS may lead to interpretation variability and lower
reproducibility among pathologists.
In previous studies, observer variability was gen-
erally assessed in multiple histotypes of RCC includ-
ing conventional, papillary and chromophobe tumors
[10,11,16,22] (Table 3). In our study, the intraobserver
and interobserver variability of FGS was only evalu-
ated in the conventional subtype. In the literature,
only one study by Ficarra et al included solely con-
ventional subtype, although the intraobserver agree-
ment of FGs was not studied in this study [9]. They
reported that the interobserver agreement between
two pathologists for 388 conventional RCCs was good
(κ= 0.44). In our study, the intraobserver (κ= 0.48) and
interobserver (κ = 0.41) agreement between the five
pathologists for FGS was also good. Compared with
the results of Ficarra et al, our results for interobserver
agreement were slightly lower. However, our results
showed better κ values than studies evaluating FGS
for multiple RCC histotypes [10,11,16,22].
Several variants of FGS including three- or two-
tiered schemes have recently been proposed
[5,10,11,23]. In addition to the four-tiered FGS, in the
present study, all variants of the three- and two-tiered
FGS were evaluated in terms of intraobserver and
interobserver agreement. The intraobserver and inter-
observer agreement for all two- and three-tiered FGS
were higher than that for the four-tiered FGS. The
greatest agreement was found for modification 2B.
The intraobserver and interobserver agreement for the
two-tiered FGS for multiple RCC histotypes was 0.53
and 0.45, respectively, in the study by Al-Aynati et al
[11]. Lang et al reported that the interobserver agree-
ment for three-tiered (grades 1 + 2, 3 and 4) and two-
tiered (grades 1 + 2 and 3 + 4) FGS in multiple RCC
histotypes was 0.34 and 0.44, respectively [10]. The
intraobserver and interobserver κ values in these
studies were lower than those in the present study.
However, both of those studies evaluated the observer
variability in multiple histotype RCC. These discrep-
ancies may be explained by the fact that FGS is more
adaptable for conventional RCC than other histotypes.
The associations between the Fuhrman nuclear
grade, stage and tumor size have been confirmed in
several studies [4,9,16]. In this study, we found that
pathologic stage and tumor size were most strongly
correlated with the two-tiered (modification 2B) FGS.
Modification 2B (low grade and high grade) may be
more reliable for evaluating the pathologic status and
prognosis of conventional RCC.
The Fuhrman nuclear grading was shown to be
significantly correlated with survival and pathologic
variables of RCC [4,9,24,25]. However, in terms 
of reproducibility, studies measuring the intraob-
server and interobserver agreement on FGS show
Table 3. Intraobserver and interobserver agreement on Fuhrman nuclear grading for renal cell carcinoma in several
studies
Reference
No. of 
Histotype
No. of Intraobserver
Interobserver agreement
cases observers agreement
Lanigan et al, 1994 [22] 88 Multiple 4 Not reported Mean κ = 0.33
Bretheau et al, 1995 [16] 190 Multiple 2 Not reported 95% (κ value not reported)
Al-Aynati et al, 2003 [11] 99 Multiple 4 Mean κ = 0.45 Mean κ = 0.29
Ficarra et al, 2005 [9] 388 Conventional 2 Not reported κ = 0.44
Lang et al, 2005 [10] 255 Multiple 3 Not reported Mean κ = 0.22
Current study 110 Conventional 5 Mean κ = 0.48 Mean κ = 0.41
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inconsistent results. Thus, there is a need for better
standardized and more reproducible criteria reflect-
ing the heterogeneity of nuclear and nucleolar fea-
tures within a tumor. In addition, collapsing the FGS
into a two-tiered (low grade and high grade) scheme
can improve the intraobserver and interobserver
reproducibility. The use of a two-tiered (particularly
modification 2B) FGS may provide more objective
assessment and prognostic advantages for conven-
tional RCC.
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